We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mutations in Gene Show Predisposition to Artery-Damaging Disease

By LabMedica International staff writers
Posted on 20 Dec 2016
Scientists have discovered that loss-of-function alterations in the YY1AP1 gene can lead to fibromuscular dysplasia (FMD) or similar arterial diseases, including Grange syndrome. More...
The link helps explain what causes this class of arterial disease, which often strikes without warning, as there is currently no test to assess risk of developing FMD.

“This is an important step in understanding the underlying molecular mechanisms of this unexplained and puzzling condition that often affects women,” said Dianna Milewicz, MD, PhD, University of Texas Health Science Center at Houston (Houston, TX, USA), who led the team that made the discovery, “The finding is a critical step in developing treatments.”

The study involved a family with a rare genetic disorder, Grange syndrome, which is also characterized by abnormal cell development on arterial walls. Grange syndrome is characterized by severe and early onset FMD-like arterial disease. “When we compared the chromosome sequence of family members with and without Grange syndrome, we identified mutations in a gene, called YY1AP1, in affected individuals,” said Dongchuan Guo, PhD, the study’s lead author and an associate professor at McGovern Medical School.

Mutations in YY1AP1 causing Grange syndrome were confirmed in additional unrelated families. The team also confirmed their findings through cell biology studies and performed genetic testing involving 282 people with FMD and a control cohort. “This is a good example of how the investigation of a very rare genetic condition that has been identified in only a few individuals can lead to a better understanding of a more common medical problem such as FMD, which may benefit a broader population,” said Dorothy K. Grange, MD, study co-author and a professor at Washington University School of Medicine.

FMD can involve the arteries going to and within the brain, leading to strokes and transient ischemic attacks; it can affect the arteries going to the kidneys, leading to high blood pressure. When doctors suspect a person has FMD, they typically order imaging to see if they can locate the narrowed artery or arteries. While there is no cure, in severe cases, doctors insert tiny wires or catheters into the blood vessels to widen them.

“Diagnosis and treatment of patients with FMD remains a clinical challenge. The recent discovery of Dr. Milewicz and her team is a significant leap toward better understanding of the causative factors in this mysterious disease,” said Ali Azizzadeh, MD, chief of vascular and endovascular surgery at McGovern Medical School.

“YY1AP1 mutations predispose to vascular lesions characteristic of FMD, thus indicating that FMD can result from mutations in a single gene,” the authors wrote, “Thus, these data provide insight into the pathogenesis of FMD, an unusual and poorly understood vascular disease.”

The study, by Guo DC et al, was published December 8, 2016, in the journal The American Journal of Human Genetics.

Related Links:
University of Texas Health Science Center at Houston


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Pathology

view channel
Image: The new system allows surgeons to identify genotyping of brain tumors and determine optimal resection margins during surgery (Photo courtesy of Nagoya University)

New Technique Detects Genetic Mutations in Brain Tumors During Surgery within 25 Minutes

Determining the genetic profile of brain tumors during surgery is crucial for improving patient outcomes, but conventional analysis methods can take up to two days, delaying critical decisions.... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.